H
Huyen Tran
High Impact
Director, Haemophilia Treatment Centre and Head, Haemostasis Thrombosis Unit
faculty
30 h-index
220 pubs
3,911 cited
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Huyen Tran is a researcher focused on haemostasis and thrombosis, with a particular emphasis on conditions like haemophilia and vaccine-induced immune thrombotic thrombocytopenia (VITT). Tran's work includes investigating the efficacy and safety of novel treatments for haemophilia, such as fitusiran and concizumab, as evidenced by their participation in multicenter, randomized phase 3 trials.
Tran's research also addresses critical public health issues, including the diagnosis and management of VITT following COVID-19 vaccination. This involves understanding the underlying immune responses to different vaccine types and their association with thrombotic events. Additionally, Tran has explored the impact of haemophilia on health-related quality of life in adolescents and adults.
With a substantial publication record (220 publications, 3,850 citations, h-index of 30), Tran is recognized as a highly cited researcher. Their recent work also touches upon rapid diagnostic techniques for viral RNA detection, demonstrating a breadth of interest in infectious disease research and molecular biology applications.
Metrics
- h-index: 30
- Publications: 220
- Citations: 3,911
Selected Publications
-
Enhanced Kalman with Adaptive Appearance Motion SORT for Grounded Generic Multiple Object Tracking (2024)
Collaboration Network
Top Collaborators
Sanjeev Chunilal
Monash University (AU)
10 shared publications
- Assessment of immunological anti‐platelet factor 4 antibodies for vaccine‐induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: A multicenter study comprising 1284 patients
- Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia
- The first known case of vaccine‐induced thrombotic thrombocytopenia in Australia
- Anticoagulation Strategies in Non–Critically Ill Patients with Covid-19
- Upper Extremity Deep Vein Thrombosis: Current Knowledge and Future Directions
Showing 5 of 10 shared publications
James D. McFadyen
Baker Heart and Diabetes Institute (AU)
10 shared publications
- A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines
- Activation of circulating platelets in vaccine‐induced thrombotic thrombocytopenia and its reversal by intravenous immunoglobulin
- Congenital fibrinogen disorders: Strengthening <scp>genotype–phenotype</scp> correlations through novel genetic diagnostic tools
- Understanding vaccine‐induced thrombotic thrombocytopenia (VITT)
- Inherited Thrombophilias Are Associated With a Higher Risk of COVID-19–Associated Venous Thromboembolism: A Prospective Population-Based Cohort Study
Showing 5 of 10 shared publications
Vivien Chen
Anzac Research Institute (AU)
9 shared publications
- Australian and New Zealand approach to diagnosis and management of vaccine‐induced immune thrombosis and thrombocytopenia
- A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia
- The first known case of vaccine‐induced thrombotic thrombocytopenia in Australia
- Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data
- Understanding vaccine‐induced thrombotic thrombocytopenia (VITT)
Showing 5 of 9 shared publications
Johnny Mahlangu
University of the Witwatersrand (ZA)
6 shared publications
- Phase 3 Trial of Concizumab in Hemophilia with Inhibitors
- Health‐related quality of life and health status in adolescent and adult people with haemophilia A without factor VIII inhibitors—A non‐interventional study
- Real-World Rates of Bleeding, Factor VIII Use, and Quality of Life in Individuals with Severe Haemophilia A Receiving Prophylaxis in a Prospective, Noninterventional Study
- Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1
- Disease and treatment burden of patients with haemophilia entering the explorer6 non‐interventional study
Showing 5 of 6 shared publications
Víctor Jiménez‐Yuste
Hospital Universitario La Paz (ES)
5 shared publications
- Phase 3 Trial of Concizumab in Hemophilia with Inhibitors
- Health‐related quality of life and health status in adolescent and adult people with haemophilia A without factor VIII inhibitors—A non‐interventional study
- Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial
- International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia—A Critical Appraisal
- Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand Disease
Philip Choi
ACT Government
5 shared publications
- Australian and New Zealand approach to diagnosis and management of vaccine‐induced immune thrombosis and thrombocytopenia
- Assessment of immunological anti‐platelet factor 4 antibodies for vaccine‐induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: A multicenter study comprising 1284 patients
- A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia
- Immune thrombocytopenia following vaccination during the COVID-19 pandemic
- The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: a population-based study
Flora Peyvandi
University of Milan (IT)
4 shared publications
- Health‐related quality of life and health status in adolescent and adult people with haemophilia A without factor VIII inhibitors—A non‐interventional study
- Real-World Rates of Bleeding, Factor VIII Use, and Quality of Life in Individuals with Severe Haemophilia A Receiving Prophylaxis in a Prospective, Noninterventional Study
- Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1
- Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE study
Jennifer Curnow
Westmead Hospital (AU)
4 shared publications
- Australian and New Zealand approach to diagnosis and management of vaccine‐induced immune thrombosis and thrombocytopenia
- Anticoagulation Strategies in Non–Critically Ill Patients with Covid-19
- Immune thrombocytopenia following vaccination during the COVID-19 pandemic
- Two Weeks of Low Molecular Weight Heparin for Isolated Symptomatic Distal Vein Thrombosis (TWISTER study)
Karlheinz Peter
Baker Heart and Diabetes Institute (AU)
4 shared publications
- Activation of circulating platelets in vaccine‐induced thrombotic thrombocytopenia and its reversal by intravenous immunoglobulin
- Inherited Thrombophilias Are Associated With a Higher Risk of COVID-19–Associated Venous Thromboembolism: A Prospective Population-Based Cohort Study
- Improving the rate of inferior vena cava filter retrieval through multidisciplinary engagement
- Inherited Thrombophilias Are Associated With a Higher Risk of COVID-19-Associated Venous Thromboembolism: A Prospective Population-Based Cohort Study.
Andreas Greinacher
Universitätsmedizin Greifswald (DE)
4 shared publications
- Vaccine‐induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources
- Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination
- Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data
- Vaccine‐induced immune thrombotic thrombocytopenia (VITT) ‐ update on diagnosis and management considering different resources: Response to Comment from Yamada et al
Florian Länger
Universität Hamburg (DE)
4 shared publications
- Vaccine‐induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources
- Vaccine‐induced immune thrombotic thrombocytopenia (VITT) ‐ update on diagnosis and management considering different resources: Response to Comment from Yamada et al
- International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia—A Critical Appraisal
- Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand Disease
Sue Pavord
Oxford University Hospitals NHS Trust (GB)
4 shared publications
- Vaccine‐induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources
- Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination
- Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data
- Vaccine‐induced immune thrombotic thrombocytopenia (VITT) ‐ update on diagnosis and management considering different resources: Response to Comment from Yamada et al
Guy Young
Children's Hospital of Los Angeles (US)
4 shared publications
- Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial
- Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial
- Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE study
- Efficacy and Safety of Fitusiran Prophylaxis, an siRNA Therapeutic, in a Multicenter Phase 3 Study (ATLAS-INH) in People with Hemophilia A or B, with Inhibitors (PwHI)
Jameela Sathar
KPJ Ampang Puteri Specialist Hospital (MY)
4 shared publications
- Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial
- Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial
- Efficacy and Safety of Fitusiran Prophylaxis, an siRNA Therapeutic, in a Multicenter Phase 3 Study (ATLAS-INH) in People with Hemophilia A or B, with Inhibitors (PwHI)
- Disease and treatment burden of patients with haemophilia entering the explorer6 non‐interventional study
Hannah Stevens
Australian Centre for HIV and Hepatitis Virology Research (AU)
4 shared publications
- A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines
- Inherited Thrombophilias Are Associated With a Higher Risk of COVID-19–Associated Venous Thromboembolism: A Prospective Population-Based Cohort Study
- Improving the rate of inferior vena cava filter retrieval through multidisciplinary engagement
- Inherited Thrombophilias Are Associated With a Higher Risk of COVID-19-Associated Venous Thromboembolism: A Prospective Population-Based Cohort Study.
Similar Researchers
Based on overlapping research topics
Winthrop Harvey
University of Arkansas at Fayetteville
Advanced Neural Network Applications
Computer Graphics and Visualization Techniques
Robotics and Sensor-Based Localization
Naga Venkata Sai Raviteja Chappa
University of Arkansas at Fayetteville
Advanced Neural Network Applications
Computer Graphics and Visualization Techniques
Robotics and Sensor-Based Localization
Minseo Jeon
Hendrix College
Advanced Neural Network Applications
Computer Graphics and Visualization Techniques
Robotics and Sensor-Based Localization
Kim Hoang Tran
University of Arkansas at Fayetteville
Advanced Neural Network Applications
Computer Graphics and Visualization Techniques
Robotics and Sensor-Based Localization
Zhong Su
University of Arkansas for Medical Sciences
Advanced Neural Network Applications
Computer Graphics and Visualization Techniques
Robotics and Sensor-Based Localization
Gerry Ezell
University of Arkansas for Medical Sciences
Venous Thromboembolism Diagnosis and Management
Immune Response and Inflammation
COVID-19 Clinical Research Studies